Allscripts (MDRX) volatility flat into investor day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting
March 22, 2017 7:34 AM EDTCantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company indicated that its customer satisfaction scores among US acute care hospitals improved by 16% in 2016 vs. 2015 levels. MDRX is also leveraging its investments in dbMotion... More
Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day
March 22, 2017 7:01 AM EDTJefferies reiterated a Buy rating and $16.50 price target on Allscripts (NASDAQ: MDRX) following the company's investor day.
Analyst Sean Dodge commented, "MDRX is firmly on a path toward more sustainable revenue growth which when coupled with its lean cost structure should... More
